Retrospective Cohort Study of Low-Flow Extracorporeal Carbon Dioxide Removal (ECCO2R) System: Evaluating ECCO2R's Efficacy and Safety in Participants With Respiratory Failure

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHong Kong University

About this trial

This is an observational study performed by retrospective review of data routinely collected for patients receiving low-flow extracorporeal carbon dioxide removal (ECCO2R) therapy in intensive care units (ICUs). Our aim is to firstly, describe the local practice in terms of patient selection and technical details of clinical management related to the use of low-flow ECCO2R system, and secondly, the clinical results in terms of patient outcomes and adverse events. These findings may allow clinicians to improve the quality and safety of ECCO2R therapy provision in the ICU.

Eligibility criteria

Qualifiers

Patients supported with ECCO2R in one of the designated study sites

Admitted to the ICU between 1 Jan 2022 and 30 June 2024

Disqualifiers

Patients younger than 18 years old

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

59 Participants
are grouped into 1 trial group

Sponsors and collaborators

Hong Kong University

Lead sponsor

Hospital Authority, Hong Kong

Sponsor institution